Literature DB >> 12495598

Frequency and trends of occupational asthma due to toluene diisocyanate: a critical review.

Werner F Diller1.   

Abstract

In recent years, occupational asthma has become the most frequent occupational lung disease in many countries. Reports and statements on the frequency of occupational asthma due to isocyanates are quite contradictory. In order to clarify the issue, a critical review of the medical literature of the past half century worldwide has been performed, with special emphasis on toluene diisocyanate (TDI) as the main representative of the isocyanate family. Nine longitudinal workplace studies of 2,751 persons under risk allow calculation of incidences of occupational asthma due to toluene diisocyanate. Annual incidences had repeatedly been above five percent before 1980, and have decreased to zero to 0.7 percent since 1980. There is a downward trend during the last half century that clearly parallels the downward trend of toluene diisocyanate exposure in some studies. Prevalences of occupational asthma due to toluene diisocyanate can be estimated from 10 cross-sectional studies, based on 788 persons. Prevalences had repeatedly been above 10 percent before 1985, and have been mostly between zero and 10 percent in recent years.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12495598     DOI: 10.1080/10473220290107075

Source DB:  PubMed          Journal:  Appl Occup Environ Hyg        ISSN: 1047-322X


  11 in total

1.  Surveillance for isocyanate asthma: a model based cost effectiveness analysis.

Authors:  D M Wild; C A Redlich; A D Paltiel
Journal:  Occup Environ Med       Date:  2005-11       Impact factor: 4.402

2.  Host factors in occupational diisocyanate asthma: a Swiss longitudinal study.

Authors:  M Berode; M Jost; M Ruegger; H Savolainen
Journal:  Int Arch Occup Environ Health       Date:  2005-02-16       Impact factor: 3.015

3.  Medical Monitoring for Occupational Asthma Among Toluene Diisocyanate Production Workers in the United States.

Authors:  Laura D Cassidy; Brent Doney; Mei Lin Wang; Laura Kurth; Patrick R Conner; James J Collins; Michael Carson; Don Molenaar; Carrie A Redlich; Eileen Storey
Journal:  J Occup Environ Med       Date:  2017-12       Impact factor: 2.162

4.  Characterization of methylene diphenyl diisocyanate-haptenated human serum albumin and hemoglobin.

Authors:  Morgen Mhike; Itai Chipinda; Justin M Hettick; Reuben H Simoyi; Angela Lemons; Brett J Green; Paul D Siegel
Journal:  Anal Biochem       Date:  2013-06-04       Impact factor: 3.365

Review 5.  Occupational asthma risk from exposures to toluene diisocyanate: A review and risk assessment.

Authors:  Robert D Daniels
Journal:  Am J Ind Med       Date:  2018-02-01       Impact factor: 2.214

Review 6.  Occupational asthma in Korea.

Authors:  Sung Soo Oh; Kyoo Sang Kim
Journal:  J Korean Med Sci       Date:  2010-12-15       Impact factor: 2.153

7.  Incidence of Occupational Asthma and Exposure to Toluene Diisocyanate in the United States Toluene Diisocyanate Production Industry.

Authors:  James J Collins; Steve Anteau; Patrick R Conner; Laura D Cassidy; Brent Doney; Mei Lin Wang; Laura Kurth; Michael Carson; Don Molenaar; Carrie A Redlich; Eileen Storey
Journal:  J Occup Environ Med       Date:  2017-12       Impact factor: 2.162

8.  Opportunities and obstacles in translating evidence to policy in occupational asthma.

Authors:  Susan M Tarlo; Ahmed A Arif; George L Delclos; Paul Henneberger; Jenil Patel
Journal:  Ann Epidemiol       Date:  2017-03-31       Impact factor: 3.797

9.  Serum Periostin Levels: A Potential Serologic Marker for Toluene Diisocyanate-Induced Occupational Asthma.

Authors:  Ji Ho Lee; Sang Ha Kim; Youngwoo Choi; Hoang Kim Tu Trinh; Eun Mi Yang; Ga Young Ban; Yoo Seob Shin; Young Min Ye; Kenji Izuhara; Hae Sim Park
Journal:  Yonsei Med J       Date:  2018-12       Impact factor: 2.759

10.  Risk Assessment for Toluene Diisocyanate and Respiratory Disease Human Studies.

Authors:  Robert M Park
Journal:  Saf Health Work       Date:  2020-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.